key: cord-0737895-3libpyuc
authors: Rah, Kang H.; Platovsky, Anna
title: In Response
date: 2020-05-12
journal: Anesth Analg
DOI: 10.1213/ane.0000000000004963
sha: d61978230e6f9a32bb751b1d1dd451b4d2611d4e
doc_id: 737895
cord_uid: 3libpyuc

nan

In Response W e thank Drs Hagan et al 1, 2 for their kind response to our article. In our article, 2 we emphasized the possibility of spreading severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to endoscopy team members in an ambulatory endoscopy center. Viral transmission may occur during the asymptomatic period of coronavirus disease of 2019 (COVID-19) via aerosolized viral particles generated from vomitus and stool or body fluids leaked via the endoscopic equipment.

We agree with Drs Hagan et al 2 that all personnel in the procedure room for upper and lower gastrointestinal (GI) endoscopies should strictly adhere to guidelines for aerosol-generating procedures per the Centers for Disease Control and Prevention. Patients undergoing GI endoscopic procedures in the hospital setting generally have more complicated medical issues requiring procedures of longer duration or endotracheal intubation and extubation, all of which increase the potential to generate virus-containing aerosols.

More than 40% of all SARS-CoV-2 infections may be transmitted before the index case becoming symptomatic. 3 Some patients with COVID-19 initially present with GI symptoms (anorexia, nausea, vomiting, abdominal pain) without respiratory symptoms or fever. 4 A report from China indicates that unrecognized infections were the source of 79% of documented cases of COVID-19. 5 Undocumented patients include asymptomatic patients, patients with mild disease not sick enough to warrant medical attention, and patients with only mild GI symptoms. These groups of patients facilitate rapid dissemination of COVID-19 and are a major source of documented cases leading to a rapid pandemic status. 6 For these reasons, we strongly agree with Drs Hagan et al 2 that we should make every effort to prevent the transmission of this virus, including administration of a reliable diagnostic test, such as a reverse transcription polymerase chain reaction before the procedure and taking strict protective measures, including effective use of personal protective equipment.

Ultimately the suspension order for performing elective endoscopies will end. All patients undergoing GI endoscopies should be considered as a high-risk opportunity for the spread of SARS-CoV-2 to other patients and endoscopy team members until the transmission of COVID-19 has been significantly contained or an effective vaccine has been administered.

Determining urgent/emergent status of gastrointestinal endoscopic procedures in an ambulatory care setting during the COVID-19 pandemic: additional factors that need to be considered

A response to: determining urgent/emergent status of gastrointestinal (GI) endoscopic procedures in an ambulatory care setting during the coronavirus disease of 2019 (COVID-19)

Temporal dynamics in viral shedding and transmissibility of COVID-19

Review article: gastrointestinal features in COVID-19 and the possibility of fecal transmission

Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

Digestive symptoms in COVID-19 patients with mild disease severity: clinical presentation, stool viral RNA testing, and outcomes